CA2528162A1 - Pni microarray and uses - Google Patents

Pni microarray and uses Download PDF

Info

Publication number
CA2528162A1
CA2528162A1 CA002528162A CA2528162A CA2528162A1 CA 2528162 A1 CA2528162 A1 CA 2528162A1 CA 002528162 A CA002528162 A CA 002528162A CA 2528162 A CA2528162 A CA 2528162A CA 2528162 A1 CA2528162 A1 CA 2528162A1
Authority
CA
Canada
Prior art keywords
pni
microarray
psychoneuroendocrinimmune
microarrays
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002528162A
Other languages
French (fr)
Inventor
Ainsley Nicholson
Suzanne D. Vernon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centers of Disease Control and Prevention CDC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2528162A1 publication Critical patent/CA2528162A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Disclosed are compositions and methods for microarrays comprising genes involved in psychoneuroendocrinimmune (PNI) activity.

Claims
CA002528162A 2003-06-04 2004-06-04 Pni microarray and uses Abandoned CA2528162A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47591503P 2003-06-04 2003-06-04
US60/475,915 2003-06-04
PCT/US2004/017686 WO2004108899A2 (en) 2003-06-04 2004-06-04 Pni microarray and uses

Publications (1)

Publication Number Publication Date
CA2528162A1 true CA2528162A1 (en) 2004-12-16

Family

ID=33511730

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002528162A Abandoned CA2528162A1 (en) 2003-06-04 2004-06-04 Pni microarray and uses

Country Status (3)

Country Link
AU (1) AU2004245998A1 (en)
CA (1) CA2528162A1 (en)
WO (1) WO2004108899A2 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7094572B2 (en) 2003-03-14 2006-08-22 Bristol-Myers Squibb Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1538219A1 (en) * 2003-12-04 2005-06-08 Erasmus University Medical Center Rotterdam Method to diagnose or screen for type 1 diabetes mellitus
CA2693280C (en) 2004-04-09 2017-09-12 Monsanto Technology Llc Compositions and methods for control of insect infestations in plants
WO2005114206A2 (en) * 2004-05-13 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a)
WO2006029184A2 (en) 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US7794933B1 (en) 2005-01-04 2010-09-14 Myriad Genetics, Inc. Depression-related gene
WO2006078911A2 (en) * 2005-01-19 2006-07-27 Genzyme Corporation Gitr antibodies for the diagnosis of nsclc
EP1865981A2 (en) * 2005-04-07 2007-12-19 Chiron Corporation Cacna1e in cancer diagnosis, detection and treatment
GB0515685D0 (en) * 2005-07-29 2005-09-07 Imp College Innovations Ltd Test
EP1930445B1 (en) * 2005-09-02 2010-03-31 Toray Industries, Inc. Kit and method for detection of urothelial cancer
AP2013006736A0 (en) 2005-09-16 2013-02-28 Monsanto Technology Llc Methods for genetic control of insect infestationsin plants and compositions thereof
US20100029504A1 (en) 2007-01-16 2010-02-04 Phigenix, Inc. Detecting pax2 for the diagnosis of breast cancer
US20070237713A1 (en) 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
WO2008021431A2 (en) * 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2008087205A1 (en) * 2007-01-19 2008-07-24 Integragen Human diabetes susceptibility sema6d gene
WO2009000520A1 (en) * 2007-06-25 2008-12-31 Universität Duisburg-Essen Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders
EP2009112A1 (en) * 2007-06-25 2008-12-31 Universität Duisburg-Essen Screening-method for polymorphic markers in HtrA1 gene in neurodegenerative disorders
CA2731643C (en) 2008-07-22 2020-05-05 The General Hospital Corporation Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
WO2010141999A1 (en) * 2009-06-12 2010-12-16 The University Of Queensland Agents and methods for diagnosing and treating ankylosing spondylitis
WO2011132086A2 (en) 2010-04-21 2011-10-27 MeMed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
US20130143954A1 (en) * 2010-06-24 2013-06-06 Genomictree, Inc. Recombinant vector for suppressing proliferation of human papilloma virus cells including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papilloma virus
FR2971258B1 (en) 2011-02-09 2020-12-04 Bio Rad Pasteur COMBINATION OF BIOMARKERS FOR THE PROGNOSIS OF A RESPONSE OR NON-RESPONSE TO ANTI-HCV TREATMENT
AU2013217935B2 (en) 2012-02-09 2018-05-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
JO3623B1 (en) 2012-05-18 2020-08-27 Amgen Inc St2 antigen binding proteins
WO2014173177A1 (en) * 2013-04-25 2014-10-30 苏州吉诺瑞生物科技有限公司 Method for transfecting protein or compound using self-assembled cell chip
AU2015302870B2 (en) 2014-08-14 2021-12-23 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
WO2016059636A1 (en) 2014-10-14 2016-04-21 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
US20190085378A1 (en) 2016-03-03 2019-03-21 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
CN108699583B (en) 2016-03-03 2022-11-01 米密德诊断学有限公司 RNA determinants for distinguishing bacterial and viral infections
WO2017197141A2 (en) * 2016-05-13 2017-11-16 Sangamo Therapeutics, Inc. Targeted treatment of androgenic alopecia
WO2018011795A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
EP4184167A1 (en) 2016-07-10 2023-05-24 MeMed Diagnostics Ltd. Early diagnosis of infections
JP7084580B2 (en) * 2016-09-23 2022-06-15 株式会社Ｄｎａチップ研究所 How to detect mood disorders
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
EP3519834A4 (en) 2016-09-29 2020-06-17 MeMed Diagnostics Ltd. Methods of risk assessment and disease classification
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN110863066A (en) * 2019-11-21 2020-03-06 廊坊诺道中科医学检验实验室有限公司 Kit for detecting five TORCH pathogens and application thereof
WO2023056193A2 (en) * 2021-09-29 2023-04-06 Chimera Bioengineering, Inc. Il-18 variants and uses thereof
CN116515993A (en) * 2023-06-25 2023-08-01 广州凯普医药科技有限公司 Primer group and kit for detecting drug genes for depression

Also Published As

Publication number Publication date
WO2004108899A2 (en) 2004-12-16
WO2004108899A3 (en) 2007-04-26
AU2004245998A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
CA2528162A1 (en) Pni microarray and uses
IL237721B (en) Nucleic acid-lipid particles comprising interfering rna, compositions comprising same and uses thereof
AU2003225644A8 (en) Wax ester synthase dna sequence, protein and uses thereof
AU2003290597A1 (en) Modified oligonucleotides for use in rna interference
AU2003277059A1 (en) Microarrays having multiple oligonucleotides in single array features
AU2002365110A1 (en) Small molecule microarrays
AU2003230762A1 (en) Chloral-free dca in oligonucleotide synthesis
WO2006074351A3 (en) Reversible nucleotide terminators and uses thereof
WO2004037988A3 (en) Methods for synthesizing complementary dna
EP1522853A4 (en) Dna microarray having standard probe and kit containing the array
AU2003218132A1 (en) Microcapillary hybridization chamber
AU2003270310A1 (en) Compositions and methods for synthesizing nucleic acids
AU2003254597A1 (en) Dna chip based genetic typing
PL376971A1 (en) Amplified genes involved in cancer
AU2003220387A1 (en) Gene amplification in cancer
AU2003234198A8 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
AP2006003557A0 (en) Antimalarial compositions and process thereof.
AU2003285489A1 (en) Nucleic acid ligands and uses therefor
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
AU2002367750A1 (en) Isothermal amplification in nucleic acid analysis
AU2003267513A1 (en) Chromosome 3, 5 and 11 genes involved in premature canities
AU2003296087A1 (en) Nucleotide derivatives and dna microarray
AU2003299467A1 (en) Canine gene microarrays
WO2005082088A3 (en) Functional genomics and gene trapping in haploid or hypodiploid cells
AU2003219570A1 (en) Novel dendritic cell-specific polynucleotides and microarray comprising the same

Legal Events

Date Code Title Description
FZDE Dead